46287-045Level 3
TADLIQ (Tadalafil)
**Product type:** Human Prescription Drug
**Active ingredient:** TADALAFIL
**Strength:** 20 mg/5mL
**Dosage form:** Suspension
**Route:** Oral
**Labeler:** CMP Pharma, Inc.
**Marketing category:** NDA (NDA214522)
**Pharmacologic class:** Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/46287-045Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.